As of June 10, 2025, XORTX Therapeutics Inc (XRX.CN) reports a ROA (Return on Assets) of -56.08%.
ROA (Return on Assets) evaluates how effectively a company turns its assets into profits, showcasing resource utilization.
Historical Trend of XORTX Therapeutics Inc's ROA (Return on Assets)
Over recent years, XORTX Therapeutics Inc's ROA (Return on Assets) has shown a stable trend. The table below summarizes the historical values:
| Date | ROA (Return on Assets) |
|---|---|
| 2020-12-31 | -56.08% |
| 2019-12-31 | -57.87% |
| 2018-12-31 | -298.44% |
| 2017-12-31 | -96.66% |
| 2017-02-28 | -222.26% |
This fluctuation highlights how XORTX Therapeutics Inc manages its efficiency in using assets to generate earnings over time.
Comparing XORTX Therapeutics Inc's ROA (Return on Assets) to Peers
To better understand XORTX Therapeutics Inc's position, it's useful to compare its ROA (Return on Assets) against industry peers. Below are selected comparisons:
| Company | ROA (Return on Assets) |
|---|---|
| XORTX Therapeutics Inc (XRX.CN) | -56.08% |
| Seedo Corp (SEDO) | 1828.23% |
| Fision Corp (FSSN) | 209.17% |
| Diego Pellicer Worldwide Inc (DPWW) | 108.45% |
| Halberd Corp (HALB) | 3.82% |
| iMining Technologies Inc (IMIN.V) | -14.49% |
Compared to its competitors, XORTX Therapeutics Inc's ROA (Return on Assets) is about average compared to peers, indicating typical asset efficiency for the industry.